Sage Therapeutics, Inc.

SAGE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$81,021$70,992$162,700$294,233
Short-Term Investments$423,397$682,192$1,109,794$1,448,063
Receivables$9,134$83,009$13,660$18,506
Inventory$0$0-$64,486$0
Other Curr. Assets$17,749$33,157$50,826$39,841
Total Curr. Assets$531,301$869,350$1,272,494$1,800,643
Property Plant & Equip (Net)$11,643$6,379$13,430$19,125
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$1,269$1,269
Tax Assets$0$0$0$0
Other NC Assets$4,278$6,548$69,256$4,251
Total NC Assets$15,921$12,927$83,955$24,645
Other Assets$0$0$0$0
Total Assets$547,222$882,277$1,356,449$1,825,288
Liabilities
Payables$12,699$10,318$18,950$10,450
Short-Term Debt$1,318$5,165$15,286$14,936
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$57,598$67,264$65,023$59,807
Total Curr. Liab.$71,615$82,747$99,259$85,193
LT Debt$10,518$0$8,982$21,928
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0-$4,391-$10,864
Total NC Liab.$10,518$0$4,591$11,064
Other Liabilities$0$0$0$0
Cap. Leases$11,836$5,165$12,134$18,432
Total Liabilities$82,133$82,747$103,850$96,257
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$2,970,325-$2,569,659-$2,028,170-$1,495,386
AOCI$244-$814-$10,206-$2,660
Other Equity$3,435,164$3,369,997$3,290,969$3,227,071
Total Equity$465,089$799,530$1,252,599$1,729,031
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$547,222$882,277$1,356,449$1,825,288
Net Debt-$69,185-$65,827-$138,432-$257,369
Sage Therapeutics, Inc. (SAGE) Financial Statements & Key Stats | AlphaPilot